Salvage or Second Autologous SCT in Relapsed Multiple Myeloma (2016–2026): A Decade in Review.
Simple Summary: Multiple myeloma is a blood cancer that often returns after initial treatment, which can include a stem cell transplant. For these relapsed patients, a second transplant is a possible treatment, but its value is being re-evaluated as newer immune-based therapies become available. Thi...
| Publicado en: | Current Oncology Vol. 31; no. 3; pp. 140 - 152 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |